Atypical antipsychotics—recent findings and new perspectives
Authors:
- 1 October 1988
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 8 (4) , 475-497
Abstract
No abstract availableThis publication has 127 references indexed in Scilit:
- Antagonism of AP-5- and amphetamine-induced behaviour by timelotem as compared with clozapine and haloperidolLife Sciences, 1987
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patientsLife Sciences, 1985
- Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaLife Sciences, 1983
- Regional blockade by neuroleptic drugs ofin vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypiesJournal of Neural Transmission, 1981
- 3H-spiroperidol binding and dopamine-stimulated adenylate cyclase: Evidence for multiple classes of receptors in primate brain regionsLife Sciences, 1978
- The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitroLife Sciences, 1978
- Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease processLife Sciences, 1978
- Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol of clozapineLife Sciences, 1977
- Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazineLife Sciences, 1976